Jogging in the Change of Osteoporosis

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03359317

Enrollment

500

Registered

2017-12-02

Start date

2018-02-20

Completion date

2019-01-30

Last updated

2017-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis

Keywords

Osteoporosis, Bone Diseases

Brief summary

To test the changes in osteoarthritis according to the X-rays, and changes in bone quality before and 1 or more years after beginning the jogging

Detailed description

Patients in this research are given an entry Bone Densitometry（DEXA）scan and are required to advance from 3-minute jogging a day to 10-minute level in daily practice for 1 year as instructed. After 1 year, subsequent DEXA scans are recorded. Interested participants are also encouraged to have hip and spine X-rays, and bone quality studies on study entry and two years later. Actual subject participation, intercurrent illnesses, fractures and changes in medication are self-monitored. Results are calculated by change in bone mineral density in the lumbar spine, hips and femurs by the DEXA scan in the study. Dose-response relationships between the amount of jogging and bone mineral density are sought. Jogging-related fractures and other adverse effects are also noted.

Interventions

BEHAVIORALjogging

Jogging as instructed for 1 year

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

50 Years to 60 Years

Healthy volunteers

Yes

Inclusion criteria

Past DEXA scan and, all within 6 months of study entry, DEXA scan and normal values for: Metabolic panel, TSH, PTH, ESR (or CRP), Vitamin D 25 hydroxy, Vitamin D 1,25 dihydroxy, Urine NTX

Exclusion criteria

Known metabolic bone disease such as osteogenesis imperfecta, current treatment with steroids, chemotherapy, or currently healing fractures of lumbar spine, hips or femurs, severe heart disease

Design outcomes

Primary

Measure	Time frame	Description
DEXA T-score	1 year	Bone mineral density change in spine, hip and femur after 1 year of jogging

Secondary

Measure	Time frame	Description
Number of fractures	1 year	Number of fractures occurring while in study

Contacts

Primary ContactPeixun Zhang, MD

875274428@qq.com15210802766

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026